Arkansas SB 505: TO MANDATE THE COPRESCRIPTION OF AN OPIOID ANTAGONIST UNDER CERTAIN CONDITIONS; AND TO AMEND THE NALOXONE ACCESS ACT.

Status: Notification that SB505 is now Act 651 (as of 2021-04-14)

State: Arkansas · Session: 2021 · Bill: SB 505

Sponsors: Bledsoe, L. Johnson

View Arkansas SB 505 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.